Novo Nordisk, Gates Foundation pledge $90M to fund antiviral research for the next pandemic

Amber Tong

When the next pandemic hits, the Novo Nordisk Foundation, Open Philanthropy and the Bill & Melinda Gates Foundation don’t want the world to be scrambling …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Novo Nordisk, Gates Foundation pledge $90M to fund antiviral research for the next pandemic

Amber Tong

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Judge halts some NIH cuts after 22 states sue

Merck KGaA confirms interest in acquiring cancer biotech SpringWorks

Decade after $8B deal, Roche offloads InterMune to mysterious specialty pharma

Eli Lilly inks $630M deal for Phase 1 MASH candidate

Boehringer Ingelheim touts success in second Phase 3 lung fibrosis trial

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

No­vo Nordisk, Gates Foun­da­tion pledge $90M to fund an­tivi­ral re­search for the next pan­dem­ic

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Novo Nordisk, Gates Foundation pledge $90M to fund antiviral research for the next pandemic